Visfatin (NAMPT), elafin, and chemerin are promising candidates for both diagnostic applications and as therapeutic targets in immune-mediated, genetic, environmentally influenced, and inflammatory skin diseases such as psoriasis, primarily due to their dual pro- and anti-inflammatory properties. The gene discussed is PI3; the disease is inflammatory skin disease.